HHS Wants Time to Respond to Purdue Executives’ Suit

HHS is asking for more time to respond to a lawsuit brought by two former Purdue Pharma executives that HHS excluded from participation in federally funded healthcare programs after they pleaded guilty to misbranding OxyContin. The former executives’ 12-year exclusion from federally funded programs appears to be the first time exclusion has been imposed based on the “responsible corporate officer” doctrine, which permits plaintiffs to be charged and convicted due to their status as senior executives, HHS Office of Inspector General spokesman Donald White said.
Washington Drug Letter